Renaissance Technologies
LOXO

Renaissance Technologies’s Loxo Oncology, Inc LOXO Stock Holding History

Renaissance Technologies’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-128,800
Closed -$22M – 3767
2018
Q3 		$22M Buy
128,800
+65,600
+104% +$11M 0.02% 881
2018
Q2 		$11M Sell
63,200
-74,100
-54% -$11.1M 0.01% 1292
2018
Q1 		$15.8M Buy
+137,300
New +$14.6M 0.02% 1081
2017
Q4 		– Sell
-207,100
Closed -$19.1M – 3595
2017
Q3 		$19.1M Buy
+207,100
New +$16.1M 0.02% 925
2016
Q1 		– Sell
-20,800
Closed -$592K – 3629
2015
Q4 		$592K Buy
+20,800
New +$558K ﹤0.01% 2681

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's LOXO Position: Q4 2018 in Review

Renaissance Technologies sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 128,800 shares — an estimated $22M sold.

Renaissance Technologies first reported a position in LOXO in Q4 2015 and held it in 5 quarters. The position peaked at $22M in Q3 2018. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Renaissance Technologies reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Renaissance Technologies sold 128,800 Loxo Oncology, Inc shares in Q4 2018, an estimated $22M.
  • Renaissance Technologies first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 5 quarters.
  • Renaissance Technologies's Loxo Oncology, Inc position peaked at $22M in Q3 2018.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.